Evaluation of an Ultra-speed Picosecond Laser for Treating Tattoos
PicoS
1 other identifier
interventional
18
1 country
1
Brief Summary
The investigators developed an ultra-speed picosecond laser (20ps) with a 20gHz repetition rate that provide very promising results in vitro and in ex vivo skin to remove skin tattoos. The aim of this study is to evaluate the efficacy and tolerance of a new ultra-speed picosecond laser and to compare it to a nanosecond laser for treating black tattoos. In a first phase of the study 10 patients with black tattoos will be treated with increasing fluencies of the picosecond laser to the optimal parameters in terms of efficacy and tolerance. In a second phase, 10 additional subjects with black tattoos will be treated after central randomization on half of the tattoo with the picosecond laser (with the parameters determined in the first phase) and the other half treated with a nanosecond laser.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for phase_1
Started Jan 2018
Longer than P75 for phase_1
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
December 18, 2017
CompletedFirst Posted
Study publicly available on registry
December 29, 2017
CompletedStudy Start
First participant enrolled
January 15, 2018
CompletedPrimary Completion
Last participant's last visit for primary outcome
July 8, 2022
CompletedStudy Completion
Last participant's last visit for all outcomes
July 8, 2022
CompletedJuly 22, 2024
July 1, 2024
4.5 years
December 18, 2017
July 19, 2024
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Percentage of decrease of tattoos 2 months after the third session as compared to baseline on standardized pictures
2 month after the end of laser utilisation
Secondary Outcomes (4)
Evaluation of Pain with EVA test
2 months after one session of laser utilisation
Evaluation of tolerance
2 months after one session of laser utilisation
satisfaction evaluation of depigmanetation tattoo
2 months after one session of laser utilisation
Skin biopsies
immediately after treatment
Study Arms (2)
A- Ultra-Speed Picosecond laser
EXPERIMENTALUtilisation of Ultra-speed Picosecond laser for tattoo depigmentation
B- Nanosecond laser
ACTIVE COMPARATORUtilisation of Nanosecond laser for tattoo depigmentation
Interventions
Laser utilisation for tattoo depigmentation 1 session every month for a total of 3 sessions
Laser utilisation for tattoo depigmentation 1 session every month for a total of 3 sessions
Eligibility Criteria
You may qualify if:
- Black tattoos with surface between 10 and 100 cm²
- Skin type I to VI
You may not qualify if:
- Childbearing age women
- Active dermatosis located on the tattoo
- Personal history of hypertrophic scars or keloids
- Pigmentary or vascular lesions located on the tattoo
- Subject taking oral steroid or retinoid or have any risk of delayed healing problems
- Acquired or hereditary conditions that could leead to a delayed healing
- Allergy to xylocaine, prilocaine or lidocaine
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
CHU de Nice - Dermatologie - Hôpital Archet
Nice, 06200, France
Study Design
- Study Type
- interventional
- Phase
- phase 1
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- PARTICIPANT
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
December 18, 2017
First Posted
December 29, 2017
Study Start
January 15, 2018
Primary Completion
July 8, 2022
Study Completion
July 8, 2022
Last Updated
July 22, 2024
Record last verified: 2024-07